comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Comparative efficacy of glucagon-like peptide-1 receptor on in patients type 2 diabetes: a systematic review and network meta-analysis | Cardiovascular Diabetology Comprehensive Overview of GLP-1 RAs

Dosing Not Established: Currently, optimal dosing protocols for humans have not been established through clinical research

Sadek is a Clinical Assistant Professor of Surgery at Rutgers-Robert Wood Johnson Medical School and a Fellow of the American College of Surgeons

Read source Hunter, G

Some services may be available virtually depending on Illinois regulations and your care plan, though in-person visits are typically recommended for lab work and evaluations

Efficacy differs measurably in trials, with semaglutide showing up to about 15% average body weight reduction over extended study periods versus roughly 9% average weight loss for liraglutide at 12 months